Both in Pharmaceuticals
LB Pharmaceuticals vs Nektar Therapeutics
Over the past year LBRX returned +137.2% and NKTR returned −39.2%; their daily moves had a correlation of 0.17.
LBRX +137.2% NKTR −39.2%Growth of $1, one year, split-adjusted
| Metric | LBRX | NKTR |
|---|---|---|
| Price | $39.61 | $38.07 |
| Market cap | $1.28B | $1.30B |
| Today | −0.09% | +0.26% |
| 1 month | +6.2% | −35.7% |
| 6 months | +29.5% | −54.2% |
| Year to date | +77.9% | −10.0% |
| 1 year | +137.2% | −39.2% |
| Revenue growth (YoY) | — | −9.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −401.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 23.8× |
| Net cash | $327.8M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 69.7% |
| Short % of float | 23.0% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).